Neumora Therapeutics NMRA
NASDAQ NMRA
$0.41 -0.05 (-10.92%)
As of: Oct 21, 2026 · 1:30 PM EDT

Neumora Therapeutics (NMRA) Long-Term Debt Issuances (2025)

Updated

Neumora Therapeutics (NMRA) recorded Long-Term Debt Issuances of $38.9 million in Q4 2025.

Analysis

Neumora Therapeutics (NMRA) Long-Term Debt Issuances (2025) Analysis & Trends

For FY2025, Neumora Therapeutics reported Long-Term Debt Issuances of $57.16 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,134.50 Bn 1,103.09 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn -
3 AbbVie 500.82 Bn 473.93 Bn 12.70 Bn -
4 Merck 367.31 Bn 321.69 Bn 12.21 Bn -
5 Novartis Ag 297.77 Bn 261.76 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.35 Bn 235.04 Bn 12.86 Bn -
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn -
8 Gilead Sciences 190.59 Bn 164.79 Bn 6.22 Bn -
9 Pfizer 169.39 Bn 116.04 Bn 10.94 Bn -
10 Neumora Therapeutics 76.69 Mn -541.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 38.90 Mn
Sep 30, 2025 -136,000.00
API Access

Neumora Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=NMRA&period=max&api_key=YOUR_API_KEY